Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Aurora kinase A | ||
Ligand | BDBM50317161 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_631118 (CHEMBL1106490) | ||
IC50 | 1000±n/a nM | ||
Citation | Choi, SJ; Lee, JE; Jeong, SY; Im, I; Lee, SD; Lee, EJ; Lee, SK; Kwon, SM; Ahn, SG; Yoon, JH; Han, SY; Kim, JI; Kim, YC 5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity. J Med Chem53:3696-706 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Aurora kinase A | |||
Name: | Aurora kinase A | ||
Synonyms: | AIK | AIRK1 | ARK-1 | ARK1 | AURA | AURKA | AURKA_HUMAN | AYK1 | Aurora 2 | Aurora kinase A (AURA) | Aurora kinase A (AURKA) | Aurora kinase A (Aurora A) | Aurora kinase A (Aurora-2) | Aurora-related kinase 1 | Aurora/IPL1-related kinase 1 | BTAK | Breast tumor-amplified kinase | Breast-tumor-amplified kinase | IAK1 | STK15 | STK15 GN | STK6 | Serine/threonine kinase 15 | Serine/threonine-protein kinase 15 | Serine/threonine-protein kinase 6 | Serine/threonine-protein kinase aurora A | Serine/threonine-protein kinase aurora-A | Synonyms=AIK | aurora-2 | hARK1 | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 45830.98 | ||
Organism: | Homo sapiens (Human) | ||
Description: | O14965 | ||
Residue: | 403 | ||
Sequence: |
| ||
BDBM50317161 | |||
n/a | |||
Name | BDBM50317161 | ||
Synonyms: | (2'Z,3'E)-5-Nitro-5'-hydroxy-indirubin-3'-oxime | CHEMBL1088704 | ||
Type | Small organic molecule | ||
Emp. Form. | C16H10N4O5 | ||
Mol. Mass. | 338.2744 | ||
SMILES | Oc1ccc2[nH]c(c(N=[OH+])c2c1)-[c-]1c2cc(ccc2[nH]c1=O)[N+]([O-])=O |(-8.68,.59,;-7.35,-.18,;-7.35,-1.72,;-6.01,-2.49,;-4.68,-1.72,;-3.21,-2.2,;-2.29,-.95,;-3.21,.31,;-2.73,1.77,;-1.22,2.09,;-4.68,-.17,;-6.02,.59,;-.75,-.95,;.15,.3,;-.18,1.8,;.96,2.83,;2.43,2.36,;2.75,.85,;1.61,-.18,;1.61,-1.72,;.15,-2.19,;-.33,-3.66,;.63,4.33,;1.77,5.37,;-.84,4.8,)| | ||
Structure |